Quantum computing for near-term applications in generative chemistry and drug discovery.

Quantum computing artificial intelligence for drug discovery de novo generation of small molecules generative chemistry noisy intermediate-scale quantum (NISQ) devices quantum chemistry quantum machine learning

Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
08 2023
Historique:
received: 17 02 2023
revised: 22 05 2023
accepted: 13 06 2023
medline: 23 10 2023
pubmed: 19 6 2023
entrez: 18 6 2023
Statut: ppublish

Résumé

In recent years, drug discovery and life sciences have been revolutionized with machine learning and artificial intelligence (AI) methods. Quantum computing is touted to be the next most significant leap in technology; one of the main early practical applications for quantum computing solutions is predicted to be in quantum chemistry simulations. Here, we review the near-term applications of quantum computing and their advantages for generative chemistry and highlight the challenges that can be addressed with noisy intermediate-scale quantum (NISQ) devices. We also discuss the possible integration of generative systems running on quantum computers into established generative AI platforms.

Identifiants

pubmed: 37331692
pii: S1359-6446(23)00191-5
doi: 10.1016/j.drudis.2023.103675
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103675

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Alexey Pyrkov (A)

Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong. Electronic address: a.pyrkov@insilicomedicine.com.

Alex Aliper (A)

Insilico Medicine AI Ltd, Masdar City, Abu Dhabi, United Arab Emirates.

Dmitry Bezrukov (D)

Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong.

Yen-Chu Lin (YC)

Insilico Medicine Taiwan Ltd, Taipei, Taiwan.

Daniil Polykovskiy (D)

Insilico Medicine Canada Inc, Montreal, QC, Canada.

Petrina Kamya (P)

Insilico Medicine Canada Inc, Montreal, QC, Canada.

Feng Ren (F)

Insilico Medicine Shanghai Ltd, Shanghai, China.

Alex Zhavoronkov (A)

Insilico Medicine Hong Kong Ltd, Pak Shek Kok, New Territories, Hong Kong.

Articles similaires

Humans Artificial Intelligence COVID-19 SARS-CoV-2 Pandemics
Humans Algorithms Software Artificial Intelligence Computer Simulation
Humans Artificial Intelligence Neoplasms Prognosis Image Processing, Computer-Assisted

Classifications MeSH